In agreement with our findings, data from both the TIMER database and Oncomine showed that CA6 was significantly downregulated, while CA9 was significantly overexpressed in HNSCC patients (Figures 7 and 8). This evidence concerns the gene CA6 and head and neck squamous cell carcinoma.